StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
6
Publishing Date
2021 - 12 - 13
1
2021 - 11 - 17
1
2021 - 06 - 03
1
2021 - 05 - 27
1
2021 - 03 - 11
1
2021 - 03 - 10
1
Sector
Health technology
6
Tags
Approval
4
Fda
1
Fda approval
1
Fda-approvals
1
Israel
1
Migraine
6
N/a
1
Nurtec
1
Pharm-country
3
Presentation
1
Product-news
1
Treatment
4
Entities
Biohaven pharmaceutical holding company ltd.
6
Symbols
ABBV
58
ABT
62
ADCT
20
ADMA
18
AGIO
12
ALNY
13
AMGN
31
AMRX
17
ANIP
19
ARVL
24
AVEO
22
AZN
19
BCRX
16
BGNE
35
BIIB
26
BMY
60
BPMC
24
CALT
12
CLVS
20
CNSP
13
EPZM
19
EXEL
14
FNCTF
49
FRG
16
FST
13
GH
12
GILD
27
GSK
15
ILMN
13
IMMX
12
INCY
52
JAGX
16
JNJ
197
KMDA
16
KPTI
32
LLY
79
LTUM
15
MDT
35
MRK
52
MRNA
13
MS
21
NBR
19
NVAX
15
NVO
13
NVS
39
NVSEF
31
PAC
12
PFE
58
PRGO
63
REGN
69
RIGL
12
SNY
226
SNYNF
177
TAK
35
TEVJF
28
TMO
15
VRTX
12
VSAC
16
WGO
13
YMAB
21
Exchanges
Nyse
6
Crawled Date
2021 - 12 - 13
1
2021 - 11 - 17
1
2021 - 06 - 03
1
2021 - 05 - 27
1
2021 - 03 - 11
1
2021 - 03 - 10
1
Crawled Time
12:00
1
13:00
1
14:00
1
14:30
1
22:00
1
22:03
1
Source
www.biospace.com
5
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
approved
symbols :
Bhvn
save search
BIOHAVEN ANNOUNCES NURTEC® ODT RECEIVES FIRST GLOBAL APPROVAL OUTSIDE THE U.S. FOR PREVENTION OF MIGRAINE
Published:
2021-12-13
(Crawled : 13:00)
- biospace.com/
BHVN
|
News
0 d
|
$40.735
6.27%
820K
|
Health Technology
|
-62.39%
|
O:
-2.49%
H:
0.0%
C:
0.0%
nurtec
approval
migraine
NURTEC® ODT Approved In Kuwait For Acute Treatment Of Migraine
Published:
2021-11-17
(Crawled : 14:30)
- biospace.com/
BHVN
|
News
0 d
|
$40.735
6.27%
820K
|
Health Technology
|
-67.89%
|
O:
-0.75%
H:
0.0%
C:
0.0%
treatment
migraine
approval
Biohaven Showcases CGRP-Antagonist Franchise Data including Nurtec® ODT (rimegepant), Now Approved to Treat and Prevent Migraine Attacks, and Zavegepant with 19 Presentations at the 2021 Virtual Annual Scientific Meeting of the American Headache Society
Published:
2021-06-03
(Crawled : 12:00)
- prnewswire.com
BHVN
|
News
0 d
|
$40.735
6.27%
820K
|
Health Technology
|
-57.38%
|
O:
-0.22%
H:
1.91%
C:
-0.21%
presentation
migraine
FDA Approves Biohaven's NURTEC® ODT (rimegepant) for Prevention: Now the First and Only Migraine Medication for both Acute and Preventive Treatment
Published:
2021-05-27
(Crawled : 22:00)
- biospace.com/
BHVN
|
News
0 d
|
$40.735
6.27%
820K
|
Health Technology
|
-52.64%
|
O:
-0.01%
H:
2.56%
C:
2.0%
treatment
fda
migraine
fda approval
Biohaven's NURTEC® ODT Approved In United Arab Emirates For Acute Treatment Of Migraine
Published:
2021-03-11
(Crawled : 14:00)
- biospace.com/
BHVN
|
News
0 d
|
$40.735
6.27%
820K
|
Health Technology
|
-49.53%
|
O:
2.38%
H:
4.18%
C:
2.68%
treatment
migraine
approval
Biohaven's NURTEC® ODT Approved In Israel For Acute Treatment Of Migraine
Published:
2021-03-10
(Crawled : 22:03)
- biospace.com/
BHVN
|
News
0 d
|
$40.735
6.27%
820K
|
Health Technology
|
-52.47%
|
O:
1.54%
H:
0.95%
C:
-7.25%
israel
treatment
migraine
approval
Gainers vs Losers
89%
11%
Top 10 Gainers
MTTR
|
News
M
|
$4.65
167.24%
9.8M
|
AGBA
|
$2.355
88.4%
34M
|
Finance
EDBL
|
News
|
$6.94
84.57%
1.4M
|
CZOO
|
$8.77
75.75%
11M
|
VNRX
|
$0.84
40.0%
2.6M
|
Health Technology
OPRT
|
News
|
$3.01
33.78%
6.8M
|
Finance
MLEC
|
$1.81
29.29%
2M
|
n/a
CMAX
|
$4.12
28.35%
65K
|
Manufacturing
MTC
|
$2.0
28.21%
1.7M
|
Technology Services
PEGY
|
$0.0586
27.95%
130M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.